Exact Mass: 517.3436906000001
Exact Mass Matches: 517.3436906000001
Found 299 metabolites which its exact mass value is equals to given mass value 517.3436906000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPC(18:3(9Z,12Z,15Z)/0:0)
LysoPC(18:3(9Z,12Z,15Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(9Z,12Z,15Z)), in particular, consists of one chain of a-linolenic acid at the C-1 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
LysoPC(18:3(6Z,9Z,12Z)/0:0)
LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(6Z,9Z,12Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position. The g-linolenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(6Z,9Z,12Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position. The g-linolenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
Retapamulin
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. It is marketed as an ointment under the name brand Altabax. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
1-Hydroxy-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine
12-O-[(2S)-N,N-dimethyl-3-methylbutanoyl]-4-deoxyphorbol 13-acetate|N,N-dimethyl-12-(S-valinoyl)-13-acetyl-4alpha-4-deoxyphorbol
Arg Gln Ser Lys
Retapamulin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
1-(9Z,12Z,15Z-Octadecatrienoyl)-2-hydroxy-sn-glycero-3-phosphocholine
Asp Lys Lys Lys
Phe Pro Arg Val
Phe Pro Val Arg
Phe Arg Pro Val
Phe Arg Val Pro
Phe Val Pro Arg
Phe Val Arg Pro
Gly Lys Lys Trp
Gly Lys Trp Lys
Gly Trp Lys Lys
Ile Met Arg Val
C22H43N7O5S (517.3046228000001)
Ile Met Val Arg
C22H43N7O5S (517.3046228000001)
Ile Arg Met Val
C22H43N7O5S (517.3046228000001)
Ile Arg Val Met
C22H43N7O5S (517.3046228000001)
Ile Val Met Arg
C22H43N7O5S (517.3046228000001)
Ile Val Arg Met
C22H43N7O5S (517.3046228000001)
Lys Asp Lys Lys
Lys Gly Lys Trp
Lys Gly Trp Lys
Lys Lys Asp Lys
Lys Lys Gly Trp
Lys Lys Lys Asp
Lys Lys Arg Ser
Lys Lys Ser Arg
Lys Lys Trp Gly
Lys Asn Arg Thr
Lys Asn Thr Arg
Lys Gln Arg Ser
Lys Gln Ser Arg
Lys Arg Lys Ser
Lys Arg Asn Thr
Lys Arg Gln Ser
Lys Arg Ser Lys
Lys Arg Ser Gln
Lys Arg Thr Asn
Lys Ser Lys Arg
Lys Ser Gln Arg
Lys Ser Arg Lys
Lys Ser Arg Gln
Lys Thr Asn Arg
Lys Thr Arg Asn
Lys Trp Gly Lys
Lys Trp Lys Gly
Leu Met Arg Val
C22H43N7O5S (517.3046228000001)
Leu Met Val Arg
C22H43N7O5S (517.3046228000001)
Leu Arg Met Val
C22H43N7O5S (517.3046228000001)
Leu Arg Val Met
C22H43N7O5S (517.3046228000001)
Leu Val Met Arg
C22H43N7O5S (517.3046228000001)
Leu Val Arg Met
C22H43N7O5S (517.3046228000001)
Met Ile Arg Val
C22H43N7O5S (517.3046228000001)
Met Ile Val Arg
C22H43N7O5S (517.3046228000001)
Met Leu Arg Val
C22H43N7O5S (517.3046228000001)
Met Leu Val Arg
C22H43N7O5S (517.3046228000001)
Met Arg Ile Val
C22H43N7O5S (517.3046228000001)
Met Arg Leu Val
C22H43N7O5S (517.3046228000001)
Met Arg Val Ile
C22H43N7O5S (517.3046228000001)
Met Arg Val Leu
C22H43N7O5S (517.3046228000001)
Met Val Ile Arg
C22H43N7O5S (517.3046228000001)
Met Val Leu Arg
C22H43N7O5S (517.3046228000001)
Met Val Arg Ile
C22H43N7O5S (517.3046228000001)
Met Val Arg Leu
C22H43N7O5S (517.3046228000001)
Asn Lys Arg Thr
Asn Lys Thr Arg
Asn Arg Lys Thr
Asn Arg Thr Lys
Asn Thr Lys Arg
Asn Thr Arg Lys
Pro Phe Arg Val
Pro Phe Val Arg
Pro Arg Phe Val
Pro Arg Val Phe
Pro Val Phe Arg
Pro Val Arg Phe
Gln Lys Arg Ser
Gln Lys Ser Arg
Gln Arg Lys Ser
Gln Arg Ser Lys
Gln Ser Lys Arg
Gln Ser Arg Lys
Arg Phe Pro Val
Arg Phe Val Pro
Arg Ile Met Val
C22H43N7O5S (517.3046228000001)
Arg Ile Val Met
C22H43N7O5S (517.3046228000001)
Arg Lys Lys Ser
Arg Lys Asn Thr
Arg Lys Gln Ser
Arg Lys Ser Lys
Arg Lys Ser Gln
Arg Lys Thr Asn
Arg Leu Met Val
C22H43N7O5S (517.3046228000001)
Arg Leu Val Met
C22H43N7O5S (517.3046228000001)
Arg Met Ile Val
C22H43N7O5S (517.3046228000001)
Arg Met Leu Val
C22H43N7O5S (517.3046228000001)
Arg Met Val Ile
C22H43N7O5S (517.3046228000001)
Arg Met Val Leu
C22H43N7O5S (517.3046228000001)
Arg Asn Lys Thr
Arg Asn Thr Lys
Arg Pro Phe Val
Arg Pro Val Phe
Arg Gln Lys Ser
Arg Ser Lys Lys
Arg Ser Lys Gln
Arg Ser Gln Lys
Arg Thr Lys Asn
Arg Thr Asn Lys
Arg Val Phe Pro
Arg Val Ile Met
C22H43N7O5S (517.3046228000001)
Arg Val Leu Met
C22H43N7O5S (517.3046228000001)
Arg Val Met Ile
C22H43N7O5S (517.3046228000001)
Arg Val Met Leu
C22H43N7O5S (517.3046228000001)
Arg Val Pro Phe
Ser Lys Lys Arg
Ser Lys Gln Arg
Ser Lys Arg Lys
Ser Lys Arg Gln
Ser Gln Lys Arg
Ser Gln Arg Lys
Ser Arg Lys Lys
Ser Arg Lys Gln
Ser Arg Gln Lys
Thr Lys Asn Arg
Thr Lys Arg Asn
Thr Asn Lys Arg
Thr Asn Arg Lys
Thr Arg Lys Asn
Thr Arg Asn Lys
Val Phe Pro Arg
Val Phe Arg Pro
Val Ile Met Arg
C22H43N7O5S (517.3046228000001)
Val Ile Arg Met
C22H43N7O5S (517.3046228000001)
Val Leu Met Arg
C22H43N7O5S (517.3046228000001)
Val Leu Arg Met
C22H43N7O5S (517.3046228000001)
Val Met Ile Arg
C22H43N7O5S (517.3046228000001)
Val Met Leu Arg
C22H43N7O5S (517.3046228000001)
Val Met Arg Ile
C22H43N7O5S (517.3046228000001)
Val Met Arg Leu
C22H43N7O5S (517.3046228000001)
Val Pro Phe Arg
Val Pro Arg Phe
Val Arg Phe Pro
Val Arg Ile Met
C22H43N7O5S (517.3046228000001)
Val Arg Leu Met
C22H43N7O5S (517.3046228000001)
Val Arg Met Ile
C22H43N7O5S (517.3046228000001)
Val Arg Met Leu
C22H43N7O5S (517.3046228000001)
Val Arg Pro Phe
Trp Gly Lys Lys
Trp Lys Gly Lys
Trp Lys Lys Gly
PC(18:3/0:0)[U]
PC(18:3/0:0)
Linolenoyl lysolecithin
4-(dioctylamino)-4-(trifluoroacetyl) az
C30H42F3N3O (517.3279798000001)
[5-[[4-[2-[tert-butyl(dimethyl)silyl]oxyethyl]piperazin-1-yl]methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid
C26H44BN3O5Si (517.3143124000001)
(2-Hydroxy-3-octadeca-6,9,12-trienoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
3-cyclohexyl-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
[(1S,2R,3S,4R,6R,7R,8R,14S)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]acetate
(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
3-cyclohexyl-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide
(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
5-hexynoic acid [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester
2-aminoethyl [3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-hydroxypropyl] hydrogen phosphate
[2-acetyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
2-(2-Nonanoyloxy-3-octanoyloxypropoxy)-2-[2-(trimethylazaniumyl)ethoxy]acetate
(4E,8E)-3-hydroxy-2-(2-hydroxytridecanoylamino)tetradeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)pentadeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]pentadec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]undec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)dodeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)trideca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] pentanoate
3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]undecane-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]tetradec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradecane-1-sulfonic acid
2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodecane-1-sulfonic acid
2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyundecane-1-sulfonic acid
3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]decane-1-sulfonic acid
(E)-3-hydroxy-2-(tetradecanoylamino)tetradec-4-ene-1-sulfonic acid
(E)-2-(hexadecanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(octadecanoylamino)dec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(undecanoylamino)heptadec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-(pentadecanoylamino)tridec-4-ene-1-sulfonic acid
(E)-2-(heptadecanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadecane-1-sulfonic acid
(E)-3-hydroxy-2-(tridecanoylamino)pentadec-4-ene-1-sulfonic acid
(E)-2-(decanoylamino)-3-hydroxyoctadec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tridecane-1-sulfonic acid
(E)-2-(dodecanoylamino)-3-hydroxyhexadec-4-ene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] propanoate
[2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-hydroxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2-hydroxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxynonadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
alpha-linolenoyl-sn-glycero-3-phosphocholine
An acyl-sn-glycero-3-phosphocholine in which the acyl group (with no specified position) is alpha-linolenoyl. Formula:C26H48NO7P.
lysophosphatidylcholine 18:3
An acyl-sn-glycero-3-phosphocholine in which the acyl group contains 18 carbons with 3 double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine (18:3/0:0)
A lysophosphatidylcholine 18:3 in which the acyl group is located at position 1.
lysophosphatidylcholine (0:0/18:3)
A lysophosphatidylcholine 18:3 in which the acyl group is located at position 2.
1-alpha-linolenoyl-sn-glycero-3-phosphocholine
A PC(18:3/0:0) in which the 1-acyl group is specified as alpha-linolenoyl.
PE(21:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved